Inventaire - your friends and communities are your best library

Cross-subtype neutralizing antibodies induced in baboons by a subtype E gp120 immunogen based on an R5 primary human immunodeficiency virus type 1 envelope

author

Deborah L. Birx

1956 -

John R. Mascola

published in: Journal of Virology

date of publication: 1999-06-01

main subject: antibody

Cites articles 86

Date

Title

Authors

1998-12-01

Neutralizing antibodies from the sera of human immunodeficiency virus type 1-infected individuals bind to monomeric gp120 and oligomeric gp140

Deborah L. Birx, John R. Mascola
1998-11-01

Neutralization of syncytium-inducing primary isolates by sera from human immunodeficiency virus (HIV)-uninfected recipients of candidate HIV vaccines

Mary Lou Clements-Mann
1998-11-01

Mapping of epitopes exposed on intact human immunodeficiency virus type 1 (HIV-1) virions: a new strategy for studying the immunologic relatedness of HIV-1

Miroslaw K Gorny
1998-10-01

An envelope modification that renders a primary, neutralization-resistant clade B human immunodeficiency virus type 1 isolate highly susceptible to neutralization by sera from other clades
1998-09-01

beta-chemokines and neutralizing antibody titers correlate with sterilizing immunity generated in HIV-1 vaccinated macaques

Antonia Radaelli, Devra Davis, Jonathan L. Heeney
1998-06-18

The antigenic structure of the HIV gp120 envelope glycoprotein

Richard T. Wyatt, Peter D. Kwong
1998-06-01

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

Joseph Sodroski, Richard T. Wyatt, Peter D. Kwong
1998-06-19

A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding

Richard T. Wyatt, Peter D. Kwong
1998-06-01

A role for carbohydrates in immune evasion in AIDS.
1998-05-01

Interactions of polyclonal and monoclonal anti-glycoprotein 120 antibodies with oligomeric glycoprotein 120-glycoprotein 41 complexes of a primary HIV type 1 isolate: relationship to neutralization

Alexandra Trkola
1998-02-01

A human monoclonal antibody specific for the V3 loop of HIV type 1 clade E cross-reacts with other HIV type 1 clades

Miroslaw K Gorny, Peter Balfe, John R. Mascola
1998-01-01

Neutralization of primary and T-cell line adapted isolates of human immunodeficiency virus type 1: role of V3-specific antibodies

Peter Simmonds
1998-02-01

Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines
1998-11-01

Correlation between humoral responses to human immunodeficiency virus type 1 envelope and disease progression in early-stage infection.

Deborah L. Birx, Robert R. Redfield, John R. Mascola, Wahren B
1998-05-01

Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group.

Barney S. Graham, John R. Mascola, Robert B Belshe, Geoffrey J Gorse, Kent J. Weinhold, Julie McElrath, Lawrence Corey, Mary Lou Clements-Mann, Susan Zolla-Pazner
1997-11-01

Passage of HIV-1 molecular clones into different cell lines confers differential sensitivity to neutralization

Jane A. McKeating, Eva Maria Fenyö
1997-12-01

Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein

Nancy Sullivan
1997-06-01

Antibodies with specificity to native gp120 and neutralization activity against primary human immunodeficiency virus type 1 isolates elicited by immunization with oligomeric gp160

Deborah L. Birx, John R. Mascola
1997-04-01

Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex
1996-09-01

Human immunodeficiency virus type 1 neutralizing antibody serotyping using serum pools and an infectivity reduction assay.

Deborah L. Birx, Kenrad E. Nelson, John R. Mascola
1996-06-28

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

Christophe Combadiere
1996-06-20

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

William A Paxton
1996-06-20

Identification of a major co-receptor for primary isolates of HIV-1

Wilfried Ellmeier, Dan Littman, Richard E Sutton
1996-04-01

Human immunodeficiency virus type 1 infection despite prior immunization with a recombinant envelope vaccine regimen

Julie McElrath, David C. Montefiori, James Mullins
1996-05-10

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor,HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
1996-03-01

Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein
1996-02-01

Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Ev

Barney S. Graham, John R. Mascola, Robert B Belshe, Geoffrey J Gorse, Julie McElrath
1996-02

Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

Joseph Sodroski, Nancy Sullivan
1996-01-01

Quantitative analysis of serum neutralization of human immunodeficiency virus type 1 from subtypes A, B, C, D, E, F, and I: lack of direct correlation between neutralization serotypes and genetic subtypes and evidence for prevalent serum-dependent i
1996-01-01

Protection of MN-rgp120-immunized chimpanzees from heterologous infection with a primary isolate of human immunodeficiency virus type 1.
1995-01-01

HIV-1 neutralization: the consequences of viral adaptation to growth on transformed T cells
1995-12-01

Resistance of chimpanzees immunized with recombinant gp120SF2 to challenge by HIV-1SF2.,Resistance of chimpanzees immunized with recombinant gp120SF2 to challenge by HIV-1SF2

Nancy Haigwood

Article - wd:Q33813526

Welcome to Inventaire

the library of your friends and communities

learn more